NCT04616144

Brief Summary

The refractive combination of high hyperopia with high astigmatism is difficult to treat surgically. In addition, there are not many suitable options to offer such patients presenting with this condition. The method used at the EYE Hospital Pristina using fresh lenticule implantation by ReLex-SMILE is safe and effective method. Fresh Corneal Implantation is a safe treatment for hyperopia with high astigmatism comparing with refractive IOL implantation (loss of accommodation, endophthalmitis). Its primary objective is to increase visual acuity, accommodation process, patient satisfaction which makes patient to enjoy a happier life. We believe this study will be the future of refractive surgery for treating high hyperopia.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 4, 2020

Completed
5.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

August 27, 2024

Status Verified

August 1, 2024

Enrollment Period

1 year

First QC Date

October 26, 2020

Last Update Submit

August 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Increase of visual acuity, accommodation process

    Using fresh myopic corneal lenticule resulted in the increase of the visual acuity (far, intermediate and near vision)

    12 months

Secondary Outcomes (1)

  • Decrease of high hyperopic astigmatism

    12 months

Study Arms (1)

FRESH CORNEAL LENTICULE IMPLANTATION

OTHER

The aim of this study is to investigate the effect of fresh corneal lenticule implantation as allogenic implant that will be taken from myopic patients to implant in hyperopic patients with high astigmatism using VisuMax Femtosecond Laser-Smile module surgery with primary objective to assess(increase) visual acuity (far, intermediate, near vision) and secondary objective to stabilize(decrease) high astigmatism by reducing K values. Fresh corneal lenticule implantation as allogenic implant that we took from myopic patients (-5.0D) to implant in hyperopic patients (+4.0 D +3.0cyl) according to high K2 values. The stromal pocket diameter was 8 mm, 4mm super incision and 130-µm cap thickness.

Device: Fresh Corneal Lenticule Implantation using Relex-Smile VisuMax Femtosecond Laser

Interventions

Fresh Corneal Lenticule Implantation using ReLex-Smile

FRESH CORNEAL LENTICULE IMPLANTATION

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients with high spherical hyperopia over + 4.5 D
  • astigmatism over + 3 cyl.
  • corneal thickness minimum 450 µm and maximum 550 µm.

You may not qualify if:

  • corneal thickness over 550 µm
  • history of glaucoma
  • retinal detachment
  • cataract
  • history of ocular inflammation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eye Hospital Pristina

Pristina, 10000, Kosovo

Location

MeSH Terms

Conditions

Hyperopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Miopic Group Hyperopic Group
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Miopic Group Hyperopic Group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Ophthalmology Department

Study Record Dates

First Submitted

October 26, 2020

First Posted

November 4, 2020

Study Start

May 1, 2019

Primary Completion

May 1, 2020

Study Completion

May 1, 2026

Last Updated

August 27, 2024

Record last verified: 2024-08

Locations